Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

SELL
$190.52 - $236.72 $86,496 - $107,470
-454 Reduced 34.11%
877 $203,000
Q1 2024

Apr 12, 2024

SELL
$212.02 - $267.71 $746,098 - $942,071
-3,519 Reduced 72.56%
1,331 $287,000
Q4 2023

Jan 10, 2024

BUY
$222.59 - $267.94 $63,438 - $76,362
285 Added 6.24%
4,850 $1.26 Million
Q3 2023

Oct 10, 2023

BUY
$253.3 - $285.89 $5,319 - $6,003
21 Added 0.46%
4,565 $1.17 Million
Q2 2023

Aug 03, 2023

BUY
$275.25 - $318.06 $324,244 - $374,674
1,178 Added 35.0%
4,544 $1.29 Million
Q1 2023

Apr 10, 2023

BUY
$256.56 - $292.34 $863,580 - $984,016
3,366 New
3,366 $935,000
Q4 2018

Jan 29, 2019

SELL
$278.5 - $352.75 $264,018 - $334,407
-948 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$293.51 - $383.83 $65,159 - $85,210
222 Added 30.58%
948 $335,000
Q2 2018

Aug 07, 2018

BUY
$257.52 - $306.91 $186,959 - $222,816
726 New
726 $211,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.4B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Dynamic Advisor Solutions LLC Portfolio

Follow Dynamic Advisor Solutions LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Advisor Solutions LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Advisor Solutions LLC with notifications on news.